Target-based Classification of Drugs

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level 

 G Protein-coupled receptors
 
 Ion channels
 
 Nuclear receptors
 
 Protein kinases
 
 Cytokines and receptors
   Cytokines
   Cytokine receptors
     Interleukin receptors
     Interferon receptors
     CSF and other factor receptors
     Chemokine receptors
     Tumor necrosis factor receptors
       TNFRSF1 (CD120) [HSA:7132 7133] [KO:03158 K05141]
       TNFRSF5 (CD40) [HSA:958] [KO:K03160]
       TNFRSF8 (CD30) [HSA:943] [KO:K05145]
       TNFRSF9 (CD137) [HSA:3604] [KO:K05146]
       TNFRSF10A (TRAILR1, CD261) [HSA:8797] [KO:K04722]
       TNFRSF10B (TRAILR2, CD262) [HSA:8795] [KO:K04722]
         D06611  Lexatumumab (USAN/INN)
         D09329  Conatumumab (USAN/INN)
         D09888  Drozitumab (USAN/INN)
       TNFRSF12A (TWEAKR, CD266) [HSA:51330] [KO:K05149]
   Pattern recognition receptors
 
 Cell surface molecules and ligands
 
 Transporters
 
 Enzymes
 
 Not elsewhere classified

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: May 23, 2018

» Monoclonal antibodies only